Navigation Links
ACLU -- Myriad Genetics lawsuit will become landmark case
Date:5/14/2009

New Rochelle, NY, May 14, 2009The American Civil Liberties Union action in filing a lawsuit yesterday against Myriad Genetics is going to lead to one of the most important legal battles in the history of biotechnology, asserts Genetic Engineering & Biotechnology News (GEN). (www.genengnews.com) The ACLU charged that the patenting of two human genes linked to breast and ovarian cancer will inhibit medical research. The organization also claims that the patents are invalid and unconstitutional.

"This is going to turn into one of the watershed events in the evolution of the bioindustry," says John Sterling, Editor in Chief of GEN. "The pros and cons of patenting genes have been an ongoing, and often acrimonious series of debates, since the in re Chakrabarty decision in 1980. But this particular case seems to have taken on a life of its own with over fifteen plaintiffs. For while the lawsuit specifically centers on the patentability of two cancer-related genes, the ACLU says it plans to challenge the entire concept of patenting genes. What we have here is one group, the ACLU and its allies, contending that gene patents stifle life science research and potentially harm the health of thousands of patients. On the other side are biotech companies who maintain that without gene patents research incentives are seriously diminished and innovation is smothered."

Kenneth I. Berns, M.D., Ph.D., Editor in Chief of the peer reviewed journal, Genetic Testing and Molecular Biomarkers (http://www.liebertpub.com/gtmb), which is the official journal of the Genetic Alliance, says the "patenting of human genes is a bad idea and that healthcare in the U.S. would be enhanced if the ACLU suit prevails." Dr. Berns is also Director of the University of Florida Genetics Institute in Gainesville.

William Warren, partner at the Sutherland law firm, thinks the ACLU
'/>"/>

Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1 2

Related biology news :

1. Genetics determine optimal drug dose of common anticoagulant
2. American College of Medical Genetics responds to new FDA labeling decision for warfarin
3. Rutgers Genetics receives $7.8 million for autism research
4. UD leads $5.3-million research project on rice epigenetics
5. UD leads $5.3-million research project on rice epigenetics
6. Wasp genetics study suggests altruism evolved from maternal behavior
7. Maynard Olson receives $500,000 Gruber Genetics Prize
8. UBC discovery unlocks tree genetics, gives new hope for pine beetle defense
9. Ecologists, material scientists pursue genetics of diatoms elegant, etched casing
10. Scientists achieve major genetics breakthrough
11. Environmental epigenetics has potential for preventing and treating disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... Imaging Market by Solutions (Hardware, Software, Services), by Applications ... & others), by End-Users (Military & Defense & ... MarketsandMarkets, Thermal Imaging Market is expected to grow ... by 2020, at a Compound Annual Growth Rate ...
(Date:5/19/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
(Date:5/14/2015)... May 14, 2015 Research and Markets ... "Fingerprint Sensors Market in Smart Mobile Devices " ... believes that 2014 was a watershed year for fingerprint ... of ,Apple Pay,. Apple gave fingerprint sensors a raison ... service. Fingerprint sensors are a must-have feature in flagship ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... Anthropogenic CO 2 emissions, in addition to causing ... them to turn progressively acidic. This change has severe ... in the latest edition of the journal Science ... of the Earth,s oceans has undergone profound changes, although none ...
... The American Cancer Society estimates that 44,000 new cases ... 37,000 people will die from the disease. These are not ... to rush through replication and then stops them cold, ... M phase. Healthy cells that don,t rush are unharmed. ...
... from Parkinson,s disease, a disorder of the nervous system ... world,s population ages, it,s estimated that the number of ... several effective therapies that treat Parkinson,s symptoms, nothing slows ... what exactly causes the disease, evidence points to one ...
Cached Biology News:Oceans acidifying faster today than in past 300 million years 2Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed 2Parkinson's disease stopped in animal model 2Parkinson's disease stopped in animal model 3
(Date:5/22/2015)... 2015 Knowledgent , the data ... explores the potential of big data analytics in the ... developed to help life sciences and healthcare organizations understand ... gain critical business insights. , The life sciences and ... driven by patient profiling, compliance and regulatory requirements, and ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... 2015  The EveryLife Foundation for Rare Diseases ... Amy Klobuchar (D-MN) today for introducing ... Treatments, or OPEN ACT. Supported by ... this bipartisan legislation promises to rapidly bring hundreds ... disease patients by incentivizing drug makers to "repurpose" ...
(Date:5/21/2015)... ANGELES , May 21, 2015  CytRx ... and development company specializing in oncology, today announced ... clinical trial with aldoxorubicin for the treatment of ... brain cancer.  The open-label, multisite trial is designed ... aldoxorubicin in patients whose tumors have progressed following ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
... 30 Sinovac Biotech Ltd. (NYSE Amex: ... in China, today announced that the Company has initiated ... the new influenza A (H1N1) strain, Swine Flu, which ... the world. Sinovac has contacted various Chinese government authorities ...
... Outside In" Program to Launch at the Annual Oncology Nursing ... (Nasdaq: AMGN ) and ONS Edge , a ... they will partner alongside celebrity make-up artist and cancer survivor ... with Cancer From the Outside In . The initiative is ...
... Tigris Pharmaceuticals, Inc., a privately held drug development company, ... molecule, AFP-464, during the recent AACR 100th Annual Meeting ... advancement in the treatment of Triple Negative Breast Cancer, ... cancer," stated Edmundo Muniz, M.D., Ph.D., President and Chief ...
Cached Biology Technology:Sinovac Initiates Preparatory Activities for Swine Flu Vaccine 2Sinovac Initiates Preparatory Activities for Swine Flu Vaccine 3Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 2Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 3Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 4Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 5Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 6Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 3Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 4
B-FABP (FL-132)...
Roll of Mesh 5m x 25cm...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
... Protein Phosphatase-2A (PPase-2A) is a serine/threonine phosphatase ... is isolated as the heterodimer of 60kDa ... the ability to dephosphorylate the a-subunit of ... PPase-2A has broad substrate specificity and may ...
Biology Products: